IRIS UniCatt

Tolusso, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.542
EU - Europa 4.347
AS - Asia 4.132
SA - Sud America 832
AF - Africa 139
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 8
AN - Antartide 2
Totale 15.014
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.382
SG - Singapore 1.945
CN - Cina 980
DE - Germania 925
IT - Italia 772
BR - Brasile 678
SE - Svezia 596
PL - Polonia 528
FR - Francia 483
VN - Vietnam 372
GB - Regno Unito 203
IE - Irlanda 180
UA - Ucraina 169
IN - India 166
FI - Finlandia 148
HK - Hong Kong 123
ID - Indonesia 119
JP - Giappone 88
RU - Federazione Russa 81
CA - Canada 73
BD - Bangladesh 65
AR - Argentina 64
MX - Messico 57
TR - Turchia 55
NL - Olanda 50
BE - Belgio 49
IQ - Iraq 43
ZA - Sudafrica 39
KR - Corea 31
AT - Austria 29
CI - Costa d'Avorio 27
ES - Italia 23
VE - Venezuela 23
MA - Marocco 18
CH - Svizzera 16
CZ - Repubblica Ceca 16
PK - Pakistan 16
SA - Arabia Saudita 16
CO - Colombia 15
EC - Ecuador 15
IR - Iran 15
LT - Lituania 15
KE - Kenya 13
UZ - Uzbekistan 12
TN - Tunisia 11
PH - Filippine 10
IL - Israele 9
JO - Giordania 9
PE - Perù 9
PY - Paraguay 9
RO - Romania 9
AU - Australia 7
GR - Grecia 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
BO - Bolivia 6
CL - Cile 6
DZ - Algeria 6
EU - Europa 6
JM - Giamaica 6
NP - Nepal 6
EE - Estonia 5
LA - Repubblica Popolare Democratica del Laos 5
LV - Lettonia 5
PT - Portogallo 5
BG - Bulgaria 4
CR - Costa Rica 4
DK - Danimarca 4
HN - Honduras 4
HU - Ungheria 4
KH - Cambogia 4
LK - Sri Lanka 4
NG - Nigeria 4
SN - Senegal 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
AM - Armenia 3
AO - Angola 3
AZ - Azerbaigian 3
EG - Egitto 3
ET - Etiopia 3
GA - Gabon 3
GE - Georgia 3
KG - Kirghizistan 3
MY - Malesia 3
PA - Panama 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AQ - Antartide 2
BA - Bosnia-Erzegovina 2
DO - Repubblica Dominicana 2
GH - Ghana 2
KW - Kuwait 2
LB - Libano 2
LU - Lussemburgo 2
MM - Myanmar 2
MT - Malta 2
NO - Norvegia 2
Totale 14.986
Salva come PNG Salva come JPEG
Città #
Singapore 1.093
Chandler 640
Ashburn 541
San Jose 484
Warsaw 479
Beijing 194
Fairfield 191
New York 185
Rome 169
Ann Arbor 165
Dublin 165
Dearborn 150
Los Angeles 127
The Dalles 127
Wilmington 126
Ho Chi Minh City 122
Woodbridge 120
Seattle 113
Jakarta 110
Dallas 109
Hong Kong 109
Milan 105
Jacksonville 103
Nanjing 100
Lauterbourg 99
Munich 99
Hanoi 97
Hefei 97
San Mateo 94
Houston 87
Chicago 81
Cattolica 78
Tokyo 76
Frankfurt am Main 74
Boston 66
Helsinki 65
Cambridge 62
São Paulo 60
Bremen 51
Princeton 51
Marseille 44
Brussels 43
London 41
Council Bluffs 37
Moscow 37
Santa Clara 36
Nürnberg 32
Buffalo 31
Lawrence 31
North Bergen 31
Redwood City 30
Izmir 29
Turku 28
Abidjan 27
Pune 27
Seoul 27
Boardman 25
Nuremberg 24
Norwalk 23
Denver 22
Kent 22
Kraków 22
Montreal 22
St Louis 22
Tianjin 22
Phoenix 21
Redmond 21
Chennai 20
Kunming 20
Lancaster 20
Nanchang 20
Orem 20
Haiphong 19
Mexico City 19
Toronto 19
Baghdad 18
Lappeenranta 18
Paris 18
Atlanta 17
Da Nang 17
Rio de Janeiro 17
Amsterdam 16
Brasília 16
Hangzhou 16
Hebei 16
Johannesburg 16
Mountain View 15
San Francisco 15
Jiaxing 14
Leawood 14
Poplar 14
Portsmouth 14
Shenyang 14
Stockholm 14
Vienna 14
Brooklyn 13
Busto Arsizio 13
Curitiba 13
Roubaix 13
Santa Maria 13
Totale 8.376
Salva come PNG Salva come JPEG
Nome #
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue 438
MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis 344
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 341
B CELL DEPLETION IN DIFFUSE PROGRESSIVE SYSTEMIC SCLEROSIS: SAFETY, SKIN SCORE MODIFICATION AND IL-6 MODULATION IN AN UP TO THIRTY-SIX MONTHS FOLLOW-UP OPEN-LABEL TRIAL 314
Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis 304
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 263
MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis. 257
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis 243
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 231
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. 223
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 208
Chemerin and PEDF are metaflammation-related biomarkers of disease activity and obesity in rheumatoid arthritis 207
B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status 203
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue. 196
Synovial tissue derived characteristics are included in a nomogram for the prediction of treatment response in naïve Rheumatoid Arthritis 191
Malnutrition in COVID-19 survivors: prevalence and risk factors 190
A vascular endothelial growth factor deficiency characterises scleroderma lung disease 190
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis 184
Very early rheumatoid arthritis is the major predictor of major outcome: clinical ACR remission and radiographic non-progression. 180
Haemophilus parasuis (Glaesserella parasuis) as a Potential Driver of Molecular Mimicry and Inflammation in Rheumatoid Arthritis 180
The role of High-mobility group box protein 1 in collagen antibody-induced arthritis is dependent on Vascular endothelial growth factor. 175
COVID-19 atypical Parsonage-Turner syndrome: a case report 174
ZAP-70+ B Cell Subset Influences Response to B Cell Depletion Therapy and Early Repopulation in Rheumatoid Arthritis 172
Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study 171
B CELLS IN SYSTEMIC SCLEROSIS: A POSSIBLE TARGET FOR THERAPY 168
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 164
Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis 163
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 162
Effects of l-Arginine Plus Vitamin C Supplementation on Physical Performance, Endothelial Function, and Persistent Fatigue in Adults with Long COVID: A Single-Blind Randomized Controlled Trial 161
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 160
Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission 159
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 157
Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: A clue to interpret different chances of relapse after clinical remission? 154
Sarilumab use in severe SARS-CoV-2 pneumonia 153
Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. 145
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 144
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 142
Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases) 140
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 139
Effects of l-Arginine Plus Vitamin C Supplementation on l-Arginine Metabolism in Adults with Long COVID: Secondary Analysis of a Randomized Clinical Trial 138
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 138
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 135
Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis 133
Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations 131
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 131
Thymosin β4 and β10 in Sjögren's syndrome: Saliva proteomics and minor salivary glands expression 130
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease 130
Comparative analysis of synovial inflammation after SARS-CoV-2 infection 128
Is Citrullination Required for the Presence of Restricted Clonotypes Reacting With Type II Collagen? Comment on the Article by Chemin et al 127
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients 127
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered 122
Paradoxical arthritis occurring during anti-TNF in patients with Inflammatory Bowel Disease: histological and immunological features of a complex synovitis. 121
Intensive training programme for ultrasound-guided minimally invasive synovial tissue biopsy on knees and wrists in different phases of inflammation 120
Biomarkers of Good EULAR Response to the B Cell Depletion Therapy in All Seropositive Rheumatoid Arthritis Patients: Clues for the Pathogenesis 119
Synovial predictors of differentiation to definite arthritis in patients with seronegative undifferentiated peripheral inflammatory arthritis: MicroRNA signature, histological, and ultrasound features 119
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 119
Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19 118
Beetroot juice intake positively influenced gut microbiota and inflammation but failed to improve functional outcomes in adults with long COVID: A pilot randomized controlled trial 118
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 117
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 116
Peripheral blood CD4posCD25posFoxP3pos cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig 116
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis 114
Association between the response to B cell depletion therapy and the allele*2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients 112
Mitochondria-Derived Vesicles and Inflammatory Profiles of Adults with Long COVID Supplemented with Red Beetroot Juice: Secondary Analysis of a Randomized Controlled Trial 111
Therapeutic drug monitoring is more cost-effective than a clinically-based approach in the management of loss of response to infliximab in inflammatory bowel disease: an observational multi-centre study. 111
Depression and Endothelial Dysfunction in Psoriatic Arthritis: Is There Any Possible Relationship? 111
Synovial tissue myeloid dendritic cell subsets exhibit distinct tissue-niche localization and function in health and rheumatoid arthritis 109
Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosus 109
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 109
Minimally invasive retrieval and characterisation of tenosynovial tissue in rheumatoid arthritis: a novel approach to study at-risk, active, and remission stages 105
Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu 104
Comment on: Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease 104
Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: Influence of the disease severity and therapy on the ovarian reserve 104
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease 104
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 102
Psoriatic arthritis and depressive symptoms: does systemic inflammation play a role? 102
Correction to: Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: influence of the disease severity and therapy on the ovarian reserve (Endocrine, (2019), 63, 2, (369-375), 10.1007/s12020-018-1783-1) 101
Basic immunology may lead to translational therapeutic rationale: SARS-CoV-2 and rheumatic diseases 101
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 98
Weight Loss, The Obesity Paradox in Rheumatoid Arthritis: Is It a Paradox? Comment on the Article by Baker et al 98
Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: A case report 98
Effects of house dust mite subcutaneous immunotherapy in real-life. Immunological and clinical biomarkers and economic impact analysis 96
Prevalence and Determinants of Peripheral Microvascular Endothelial Dysfunction in Rheumatoid Arthritis Patients: A Multicenter Cross-Sectional Study 96
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 95
Prevalence and Determinants of Peripheral Microvascular Endothelial Dysfunction in Rheumatoid Arthritis Patients: A Multicenter Cross-Sectional Study. 94
Is it necessary to be citrullinated to have restricted clonotypes reacting with Collagen type II? Comment to article "A novel HLA-DRB1*10:01 restricted T cell epitope from citrullinated type II collagen relevant for Rheumatoid Arthritis" 93
The B side of rheumatoid arthritis pathogenesis 92
Do we need to apply a T2T strategy even in ACPA-negative early rheumatoid arthritis? YES 90
Should rheumatoid factor (RF) (and antinuclear antibodies (ANA)) become routinary screening test for morbidities in the general population?: From the concept of “benign autoimmunity “to the concept of” autoimmunity as a red flag in preventive medicine”? 89
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients 89
JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy 88
Laboratory Monitoring of Biological Therapies in Rheumatology: The Role of Immunogenicity 88
Evaluation of the Impact of Night Shift Work on Disease Severity in Psoriatic Patients: A Case-Control Study with Clinical, Hormonal, and Immunological Evaluation 87
Pro Nerve Growth Factor and Its Receptor p75NTR Activate Inflammatory Responses in Synovial Fibroblasts: A Novel Targetable Mechanism in Arthritis 86
Loss of α2-6 sialylation promotes the transformation of synovial fibroblasts into a pro-inflammatory phenotype in arthritis 85
Is ACPA positivity the main driver for rheumatoid arthritis treatment? Pros and cons 84
Basophil activation and serum IL-5 levels as possible monitor biomarkers in severe eosinophilic asthma patients treated with anti-IL-5 drugs 82
Measuring the T-cell down-regulation of TCR-zeta, ZAP-70 and CD28 in arthritis patients: An old tool for new biomarkers 76
Nonmedical switch of anti-TNF-α biosimilars has no major clinical, pharmacokinetic and psychological impact on patients with IBD - the SAFER Study 74
The Role of High-Mobility Group Box-1 and Its Crosstalk with Microbiome in Rheumatoid Arthritis 73
Totale 14.407
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.317
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.317
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021199 0 0 0 0 0 0 0 0 0 70 100 29
2021/2022915 119 62 38 61 65 29 28 103 41 67 133 169
2022/20231.893 220 239 150 300 117 224 92 140 235 62 63 51
2023/20241.112 42 253 46 64 45 189 81 52 14 78 160 88
2024/20252.397 48 47 176 94 200 91 101 98 357 263 476 446
2025/20265.439 840 224 404 689 931 344 1.002 278 353 374 0 0
Totale 15.221